Measurement of the endogenous adenosine concentration in humans in vivo: Methodological considerations

Current Drug Metabolism

Volumn 9, Issue 8, 2008, Pages 679-685

  Ramakers, B P ^a   Pickkers, P ^a   Deussen, A ^b   Rongen, G A ^a   van den Broek, P ^a   van der Hoeven, J G ^a   Smits, P ^a   Riksen, N P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Adenosine; Blocker solution; Concentration; Measurement; Microdialysis

Indexed keywords

9 (2 HYDROXY 3 NONYL)ADENINE; ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE KINASE; ADENOSINE RECEPTOR; ADENOSYLHOMOCYSTEINASE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM CHLORIDE; DILAZEP; DIPYRIDAMOLE; ECTO 5' NUCLEOTIDASE; EDETIC ACID; EGTAZIC ACID; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER; GLUCOSE; HEPARIN; INDOMETACIN; NORADRENALIN; PENTOSTATIN; POTASSIUM CHLORIDE;

ATHEROSCLEROSIS; BLOOD SAMPLING; CELL STRESS; COMPETITIVE INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; INTERSTITIUM; ISCHEMIA; MEMBRANE TRANSPORT; MICRODIALYSIS; NEGATIVE FEEDBACK; NUCLEOSIDE TRANSPORT; PLASMA HALF LIFE; PROTECTION; REVIEW; SENSITIVITY AND SPECIFICITY; VEIN PUNCTURE; BLOOD; CHEMISTRY; EXTRACELLULAR FLUID;

ADENOSINE; BLOOD SPECIMEN COLLECTION; EXTRACELLULAR FLUID; HUMANS; MICRODIALYSIS;

EID: 58149328826     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008786049249     Document Type: Review

References (62)

1. Drury, A.N. and Szent-Gyorgyi, A. (1929) The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol., 68, 213-237.
2. van Belle, H.; Goossens, F. and Wynants, J. (1987) Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. Am. J. Physiol., 252, H886-H893.
3. Fredholm, B. B. (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ., 14, 1315-1323.
4. Newby, A. C. (1984) Adenosine and the concept of retaliatory metabolites. Trends Biochem. Sci., 9, 42-44.
5. Fredholm, B. B.; IJzerman, A. P.; Jacobson, K. A.; Klotz, K. N. and Linden, J. (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 53, 527-552.
6. Rongen, G. A.; Floras, J. S.; Lenders, J. W.; Thien, T. and Smits, P. (1997) Cardiovascular pharmacology of purines. Clin. Sci. (Lond.), 92, 13-24.
7. Headrick, J. P.; Hack, B. and Ashton, K. J. (2003) Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am. J. Physiol. Heart Circ. Physiol., 285, H1797-H1818.
8. 2A receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model. Arterioscler. Thromb. Vasc. Biol., 21, 791-796.
9. Ohta, A. and Sitkovsky, M. (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature, 414, 916-920.
10. Riksen, N. P.; Rongen, G. A.; Boers, G. H. J.; Blom, H. J.; van den Broek, P. H. H. and Smits, P. (2005) Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol., 25, 109-114.
11. Riksen, N. P.; Oyen, W. J.; Ramakers, B. P.; Van den Broek, P. H.; Engbersen, R.; Boerman, O. C.; Smits, P. and Rongen, G. A. (2005) Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans. Clin. Pharmacol. Ther., 78, 52-59.
12. Montesinos, M. C.; Takedachi, M.; Thompson, L. F.; Wilder, T. F.; Fernandez, P. and Cronstein, B. N. (2007) The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5′-nucleotidase: findings in a study of ecto-5′-nucleotidase gene-deficient mice. Arthritis Rheum., 56, 1440-1445.
13. Sanada, S.; Asanuma, H.; Minamino, T.; Node, K.; Takashima, S.; Okuda, H.; Shinozaki, Y.; Ogai, A.; Fujita, M.; Hirata, A.; Kim, J.; Asano, Y.; Mori, H.; Tomoike, H.; Kitamura, S.; Hori, M. and Kitakaze, M. (2004) Optimal windows of statin use for immediate infarct limitation: 5′-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase. Circulation, 110, 2143-2149.
14. Moser, G. H.; Schrader, J. and Deussen, A. (1989) Turnover of adenosine in plasma of human and dog blood. Am. J. Physiol., 256, C799-C806.
15. Nees, S.; Herzog, V.; Becker, B. F.; Bock, M.; Des, R. C. and Gerlach, E. (1985) The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res. Cardiol., 80, 515-529.
16. Deussen, A. (2000) Metabolic flux rates of adenosine in the heart. Naunyn Schmiedebergs Arch. Pharmacol., 362, 351-363.
17. Deussen, A.; Stappert, M.; Schafer, S. and Kelm, M. (1999) Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient. Circulation, 99, 2041-2047.
18. Suzuki, K.; Miura, T.; Miki, T.; Tsuchida, A. and Shimamoto, K. (1998) Infarct-size limitation by preconditioning is enhanced by dipyridamole administered before but not after preconditioning: evidence for the role of interstitial adenosine level during preconditioning as a primary determinant of cardioprotection. J. Cardiovasc. Pharmacol., 31, 1-9.
19. Meijer, P.; Wouters, C. W.; Van den Broek, P. H.; Scheffer, G. J.; Riksen, N. P.; Smits, P. and Rongen, G. A. (2008) Dipyridamole enhances ischaemia-induced reactive hyperaemia by increased adenosine receptor stimulation. Br. J. Pharmacol., 153, 1169-1176.
20. Riksen, N. P.; Franke, B.; Oyen, W. J.; Borm, G. F.; van den, B. P.; Boerman, O. C.; Smits, P. and Rongen, G. A. (2007) Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene. Eur. Heart J., 28, 1085-1091.
21. Schutz, W.; Schrader, J. and Gerlach, E. (1981) Different sites of adenosine formation in the heart. Am. J. Physiol., 240, H963-H970.
22. Deussen, A.; Borst, M. and Schrader, J. (1988) Formation of S-adenosyl-homocysteine in the heart. I: An index of free intracellular adenosine. Circ. Res., 63, 240-249.
23. Ueland, P. M. (1982) Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol. Rev., 34, 223-253.
24. Deussen, A.; Henrich, M.; Hamacher, K.; Borst, M. M.; Herzog, H.; Coenen, H. H.; Stocklin, G.; Feinendegen, L. E. and Schrader, J. (1992) Noninvasive assessment of regional cardiac adenosine using positron emission tomography. J. Nucl. Med., 33, 2138-2144.
25. Dale, N.; Pearson, T. and Frenguelli, B. G. (2000) Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol., 526 Pt 1, 143-155.
26. Swamy, B. E. and Venton, B. J. (2007) Subsecond detection of physiological adenosine concentrations using fast-scan cyclic voltammetry. Anal. Chem., 79, 744-750.
27. Bergfeld, G. R. and Forrester, T. (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc. Res., 26, 40-47.
28. Sprague, R. S.; Ellsworth, M. L.; Stephenson, A. H. and Lonigro, A. J. (1996) ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am. J. Physiol., 271, H2717-H2722.
29. Moake, J. L.; Turner, N. A.; Stathopoulos, N. A.; Nolasco, L. and Hellums, J. D. (1988) Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood, 71, 1366-1374.
30. Eltzschig, H. K.; Macmanus, C. F. and Colgan, S. P. (2008) Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc. Med., 18, 103-107.
31. Gewirtz, H.; Brown, P. and Most, A. S. (1987) Measurement of plasma adenosine concentration: methodological and physiological considerations. Proc. Soc. Exp. Biol. Med., 185, 93-100.
32. Shryock, J. C.; Boykin, M. T.; Hill, J. A. and Belardinelli, L. (1990) A new method of sampling blood for measurement of plasma adenosine. Am. J. Physiol., 258, H1232-H1239.
33. Rongen, G. A.; Smits, P.; Ver Donck K.; Willemsen, J. J.; De Abreu, R. A.; Van Belle, H. and Thien, T. (1995) Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection. J. Clin. Invest., 95, 658-668.
34. Huszar, E.; Barat, E. and Kollai, M. (1996) Isocratic high-performance liquid chromatographic determination of plasma adenosine. Chromatographica, 42, 318-323.
35. Deussen, A.; Bading, B.; Kelm, M. and Schrader, J. (1993) Formation and salvage of adenosine by macrovascular endothelial cells. Am. J. Physiol., 264, H692-H700.
36. Flocke, K. and Mannherz, H. G. (1991) Isolation and characterization of 5′-nucleotidase of a human pancreatic tumor cell line. Biochim. Biophys. Acta, 1076, 273-281.
37. McCann, W. P. and Katholi, R. E. (1990) Control of artifacts in plasma adenosine determinations. Proc. Soc. Exp. Biol. Med., 194, 314-319.
38. Martin, C.; Leone, M.; Viviand, X.; Ayem, M. L. and Guieu, R. (2000) High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit. Care Med., 28, 3198-3202.
39. Slowiaczek, P. and Tattersall, M. H. (1982) The determination of purine levels in human and mouse plasma. Anal. Biochem., 125, 6-12.
40. Ontyd, J. and Schrader, J. (1984) Measurement of adenosine, inosine, and hypoxanthine in human plasma. J Chromatogr., 307, 404-409.
41. Muller, M. (2002) Science, medicine, and the future: Microdialysis. BMJ, 324, 588-591.
42. Costa, F.; Sulur, P.; Angel, M.; Cavalcante, J.; Haile, V.; Christman, B. and Biaggioni, I. (1999) Intravascular source of adenosine during forearm ischemia in humans: implications for reactive hyperemia. Hypertension, 33, 1453-1457.
43. Riksen, N. P.; van Ginneken, E. E.; Van den Broek, P. H.; Smits, P. and Rongen, G. A. (2005) In vivo evidence against a role for adenosine in the exercise pressor reflex in humans. J. Appl. Physiol., 99, 522-527.
44. Zetterstrom, T.; Vernet, L.; Ungerstedt, U.; Tossman, U.; Jonzon, B. and Fredholm, B. B. (1982) Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci. Lett., 29, 111-115.
45. Benveniste, H. (1989) Brain microdialysis. J. Neurochem., 52, 1667-1679.
46. Costa, F.; Heusinkveld, J.; Ballog, R.; Davis, S. and Biaggioni, I. (2000) Estimation of skeletal muscle interstitial adenosine during forearm dynamic exercise in humans. Hypertension, 35, 1124-1128.
47. MacLean, D. A.; Sinoway, L. I. and Leuenberger, U. (1998) Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans. Circulation, 98, 1990-1992.
48. Scheller, D. and Kolb, J. (1991) The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples. J. Neurosci. Methods, 40, 31-38.
49. Muraoka, T.; Katsuramaki, T.; Shiraishi, H. and Yokoyama, M. M. (1990) Automated enzymatic measurement of adenosine deaminase isoenzyme activities in serum. Anal. Biochem., 187, 268-272.
50. Ungerer, J. P.; Oosthuizen, H. M.; Bissbort, S. H. and Vermaak, W. J. (1992) Serum adenosine deaminase: isoenzymes and diagnostic application. Clin, Chem., 38, 1322-1326.
51. Feldman, M. D.; Ayers, C. R.; Lehman, M. R.; Taylor, H. E.; Gordon, V. L.; Sabia, P. J.; Ras, D.; Skalak, T. C. and Linden, J. (1992) Improved detection of ischemia-induced increases in coronary sinus adenosine in patients with coronary artery disease. Clin. Chem., 38, 256-262.
52. Guieu, R.; Sampieri, F.; Bechis, G. and Rochat, H. (1994) Use of HPLC to measure circulating adenosine levels in migrainous patients. Clin. Chim. Acta, 227, 185-194.
53. Maguire, M. H.; Szabo, I.; Valko, I. E.; Finley, B. E. and Bennett, T. L. (1998) Simultaneous measurement of adenosine and hypoxanthine in human umbilical cord plasma using reversed-phase high-performance liquid chromatography with photodiode-array detection and on-line validation of peak purity. J. Chromatogr. B Biomed. Sci. Appl., 707, 33-41.
54. Saito, H.; Nishimura, M.; Shinano, H.; Makita, H.; Tsujino, I.; Shibuya, E.; Sato, F.; Miyamoto, K. and Kawakami, Y. (1999) Plasma concentration of adenosine during normoxia and moderate hypoxia in humans. Am. J. Respir. Crit. Care Med., 159, 1014-1018.
55. Yoneyama, Y.; Suzuki, S.; Sawa, R.; Otsubo, Y.; Power, G. G. and Araki, T. (2000) Plasma adenosine levels increase in women with normal pregnancies. Am. J. Obstet. Gynecol., 182, 1200-1203.
56. Laghi-Pasini, F.; Guideri, F.; Petersen, C.; Lazzerini, P. E.; Sicari, R.; Capecchi, P. L. and Picano, E. (2003) Blunted increase in plasma adenosine levels following dipyridamole stress in dilated cardiomyopathy patients. J. Intern. Med., 254, 591-596.
57. Lonnroth, P.; Jansson, P. A.; Fredholm, B. B. and Smith, U. (1989) Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans. Am. J. Physiol., 256, E250-E255.
58. Hellsten, Y.; Maclean, D.; Radegran, G.; Saltin, B. and Bangsbo, J. (1998) Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation, 98, 6-8.
59. Costa, F.; Diedrich, A.; Johnson, B.; Sulur, P.; Farley, G. and Biaggioni, I. (2001) Adenosine, a metabolic trigger of the exercise pressor reflex in humans. Hypertension, 37, 917-922.
60. Lott, M. E.; Hogeman, C. S.; Vickery, L.; Kunselman, A. R.; Sinoway, L. I. and MacLean, D. A. (2001) Effects of dynamic exercise on mean blood velocity and muscle interstitial metabolite responses in humans. Am. J. Physiol. Heart Circ. Physiol., 281, H1734-H1741.
61. Langberg, H.; Bjorn, C.; Boushel, R.; Hellsten, Y. and Kjaer, M. (2002) Exercise-induced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J. Physiol., 542, 977-983.
62. Gamboa, A.; Ertl, A. C.; Costa, F.; Farley, G.; Manier, M. L.; Hachey, D. L.; Diedrich, A. and Biaggioni, I. (2003) Blockade of nucleoside transport is required for delivery of intraarterial adenosine into the interstitium: relevance to therapeutic preconditioning in humans. Circulation, 108, 2631-2635.